HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants

American Journal of Hematology

Volumn 84, Issue 11, 2009, Pages 710-714

  Barton, James C ^a,b   LaFreniere, Susie A ^c   Leiendecker Foster, Catherine ^c   Li, Honggui ^d   Acton, Ronald T ^e   Press, Richard D ^f   Eckfeldt, John H ^c  

^a SOUTHERN IRON DISORDERS CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

^e University of Alabama at Birmingham   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; ASIAN; C282Y GENE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ETHNICITY; EUROPEAN AMERICAN; FEMALE; FERRITIN BLOOD LEVEL; FTL GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC IDENTIFICATION; GENOTYPE; H63D GENE; HEMOCHROMATOSIS; HETEROZYGOSITY; HETEROZYGOTE; HFE GENE; HISPANIC; HJV GENE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; SLC40A1 GENE; TFR2 GENE;

ANTIMICROBIAL CATIONIC PEPTIDES; APOFERRITINS; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; ETHNIC GROUPS; FERRITINS; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; LINKAGE DISEQUILIBRIUM; MEMBRANE PROTEINS; MUTATION; MUTATION, MISSENSE; RECEPTORS, TRANSFERRIN; TRANSFERRIN;

EID: 70449587089     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21524     Document Type: Article

References (40)

1. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13: 399-408. (Pubitemid 26256612)
2. McLaren CE, Barton JC, Adams PC, et al. Hemochromatosis and iron overload screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci 2003;325:53-62.
3. Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 2000;133:329-337. (Pubitemid 30683579)
4. Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-1778. (Pubitemid 40570925)
5. Beutler E. Penetrance of haemochromatosis. Gut 2003;52:610-611.
6. Lee PL, Gelbart T, West C, et al. A study of genes that may modulate the expression of hereditary hemochromatosis: Transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells Mol Dis 2001;27:783-802. (Pubitemid 33145024)
7. Lazarescu A, Snively BM, Adams PC. Phenotype variation in C282Y homozygotes for the hemochromatosis gene. Clin Gastroenterol Hepatol 2005;3:1043-1046. (Pubitemid 41415754)
8. Barton JC, Acton RT, Dawkins FW, et al. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study. Genet Test 2005;9:231-241.
9. Harris EL, McLaren CE, Reboussin DM, et al. Serum ferritin and transferrin saturation in Asians and Pacific Islanders. Arch Intern Med 2007;167:722-726.
10. Gordeuk VR, Reboussin DM, McLaren CE, et al. Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population. Am J Hematol 2008;83:618-626.
11. Biasiotto G, Belloli S, Ruggeri G, et al. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. Clin Chem 2003; 49:1981-1988. (Pubitemid 37449469)
12. Cremonesi L, Foglieni B, Fermo I, et al. Identification of two novel mutations in the 50-untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning. Haematologica 2003;88:1110-1116. (Pubitemid 37362542)
13. Le Gac G, Mura C, Ferec C. Complete scanning of the hereditary hemochromatosis gene (HFE) by use of denaturing HPLC. Clin Chem 2001;47:1633-1640. (Pubitemid 32781577)
14. Cremonesi L, Stenirri S, Fermo I, et al. Denaturing HPLC analysis of DNA deletions and insertions. Hum Mutat 2003;22:98-102. (Pubitemid 36807779)
15. Cremonesi L, Forni GL, Soriani N, et al. Genetic and clinical heterogeneity of ferroportin disease. Br J Haematol 2005;131:663-670. (Pubitemid 43899633)
16. Rivers CA, Barton JC, Gordeuk VR, et al. Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Blood Cells Mol Dis 2007;38:247-252.
17. Barton JC, Acton RT, Lee PL, West C. SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub- Saharan African descent. Blood Cells Mol Dis 2007;39:206-211. (Pubitemid 47161131)
18. Beutler E, Barton JC, Felitti VJ, et al. Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans. Blood Cells Mol Dis 2003;31: 305-309. (Pubitemid 37441302)
19. Gordeuk VR, Caleffi A, Corradini E, et al. Iron overload in Africans and African- Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. Blood Cells Mol Dis 2003;31:299-304. (Pubitemid 37433868)
20. Valenti L, Pulixi EA, Arosio P, et al. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis. Haematologica 2007;92:1037-1042. (Pubitemid 350144209)
21. Jacolot S, Le Gac G, Scotet V, et al. HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. Blood 2004;103:2835-2840. (Pubitemid 38393047)
22. Steiner M, Leiendecker-Foster C, McLaren GD, et al. Hemochromatosis (HFE) gene splice site mutation IVS511 G/A in North American Vietnamese with and without phenotypic evidence of iron overload. Transl Res 2007;149: 92-95. (Pubitemid 46127546)
23. Biasiotto G, Roetto A, Daraio F, et al. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol Dis 2004;33:338-343. (Pubitemid 39446508)
24. Merryweather-Clarke AT, Cadet E, Bomford A, et al. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet 2003;12:2241-2247. (Pubitemid 37098993)
25. Barton JC, Sawada-Hirai R, Rothenberg BE, Acton RT. Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. Blood Cells Mol Dis 1999; 25:147-155. (Pubitemid 29521416)
26. Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711 hemochromatosis probands: Evidence for S65C implication in mild form of hemochromatosis. Blood 1999;93:2502-2505. (Pubitemid 29181181)
27. Kotze MJ, De Villiers JN, Bouwens CS, et al. Molecular diagnosis of hereditary hemochromatosis: Application of a newly-developed reverse-hybridization assay in the South African population. Clin Genet 2004;65:317-321.
28. Menardi G, Perotti L, Prucca M, et al. A very rare association of three mutations of the HFE gene for hemochromatosis. Genet Test 2002;6:331-334. (Pubitemid 36020060)
29. Jones DC, Young NT, Pigott C, et al. Comprehensive hereditary hemochromatosis genotyping. Tissue Antigens 2002;60:481-488.
30. Drakesmith H, Schimanski LM, Ormerod E, et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 2005;106:1092-1097. (Pubitemid 41076459)
31. De Domenico I, McVey WD, Nemeth E, et al. Molecular and clinical correlates in iron overload associated with mutations in ferroportin. Haematologica 2006;91:1092-1095. (Pubitemid 44204775)
32. Lee PL, Barton JC, Brandhagen D, Beutler E. Hemojuvelin (HJV) mutations in persons of European, African-American and Asian ancestry with adult onset haemochromatosis. Br J Haematol 2004;127:224-229. (Pubitemid 39371818)
33. Barton JC, Rivers CA, Niyongere S, et al. Allele frequencies of hemojuvelin gene (HJV) I222N and G320V missense mutations in white and African American subjects from the general Alabama population. BMC Med Genet 2004;5:29. (Pubitemid 41418124)
34. Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004;36:77-82. (Pubitemid 38056211)
35. Acton RT, Snively BM, Barton JC, et al. A genome-wide linkage scan for iron phenotype quantitative trait loci: The HEIRS Family Study. Clin Genet 2007; 71:518-529.
36. Lanzara C, Roetto A, Daraio F, et al. Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 2004;103:4317-4321. (Pubitemid 38685379)
37. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33: 21-22. (Pubitemid 36068676)
38. Wang X, Leiendecker-Foster C, Acton RT, et al. Heme carrier protein 1 (HCP1) genetic variants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study participants. Blood Cells Mol Dis 2009;42:150-154.
39. IDT OligoAnalyzer. Integrated DNA Technologies, Inc. July 2004. 2007.
40. Primer 3. Broad Institute July 2004. 2007.